Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

New progesterone-based compounds can block male hormones.

Amoxapine may be effective for treating ejaculatory dysfunction.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

5-ARI therapy may help prevent prostate cancer progression.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Blocking certain brain processes reduces mating behavior in female rats.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Bimatoprost treats glaucoma and promotes hair growth, with potential for more medical uses.

5α-reductase 2 is crucial for stress response in male rats.